Announced Fri, 10 Jul · 15:49 IST
Board committees reconstituted after independent director change
Management Changes View source PDF
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹86.56
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.2+0.3+0.5+1.2+3.3+0.5————
Up moveDown movePending
AI summary
Indo Us Biotech's board has reconstituted its Audit, Nomination and Remuneration, and Stakeholders Relationship committees, effective July 10, 2026. The reshuffle follows the earlier appointment of Hemanshi Darsh Soni as Additional Independent Director on April 21, 2026, filling the vacancy left by Nehaben Patel's resignation. Soni has been added as a member of all three committees.
Likely market impact
Routine governance update. No material impact on operations or shareholders expected from this committee reshuffle.